EDITORIAL
Published on 15 Dec 2014
Mitochondrial Proteins (e.g., VDAC, Bcl-2, HK, ANT) as Major Control Points in Oncology
doi 10.3389/fonc.2014.00365
- 3,201 views
- 4 citations
- Frontiers in Oncology
- Molecular and Cellular Oncology
- Research Topics
- Mitochondrial proteins (e.g. VDAC, Bcl-2, HK, ANT2...) as major control points in oncology
Mitochondrial proteins (e.g. VDAC, Bcl-2, HK, ANT2...) as major control points in oncology
18k
Total downloads
97k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 08 Mar 2013
Mitochondrial permeability transition pore as a selective target for anti-cancer therapy
doi 10.3389/fonc.2013.00041
- 11,506 views
- 68 citations
REVIEW
Published on 07 Mar 2013
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology
doi 10.3389/fonc.2013.00038
- 30,721 views
- 223 citations
MINI REVIEW
Published on 05 Feb 2013
GSK-3 and mitochondria in cancer cells
doi 10.3389/fonc.2013.00016
- 8,980 views
- 56 citations
REVIEW
Published on 02 Jan 2013
Crosstalk between Bcl-2 family and Ras family small GTPases: potential cell fate regulation?
doi 10.3389/fonc.2012.00206
- 4,908 views
- 22 citations
REVIEW
Published on 29 Nov 2012
VDAC1: from structure to cancer therapy
doi 10.3389/fonc.2012.00164
- 24,827 views
- 168 citations
REVIEW
Published on 08 Oct 2012
Shifting the balance of mitochondrial apoptosis: therapeutic perspectives
doi 10.3389/fonc.2012.00121
- 5,013 views
- 22 citations
MINI REVIEW
Published on 02 Oct 2012
Reprofiling a classical anthelmintic, pyrvinium pamoate, as an anti-cancer drug targeting mitochondrial respiration
doi 10.3389/fonc.2012.00137
- 15,700 views
- 52 citations
Published in
Frontiers in Oncology
- Molecular and Cellular Oncology
Impact
- 97kTopic views
- 77kArticle views
- 18kArticle downloads